155 related articles for article (PubMed ID: 8864756)
21. Immunomodulation and adenoviral gene transfer to the lungs of nonhuman primates.
Shean MK; Baskin G; Sullivan D; Schurr J; Cavender DE; Shellito JE; Schwarzenberger PO; Kolls JK
Hum Gene Ther; 2000 May; 11(7):1047-55. PubMed ID: 10811233
[TBL] [Abstract][Full Text] [Related]
22. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
[TBL] [Abstract][Full Text] [Related]
23. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
Sung RS; Qin L; Bromberg JS
Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
[TBL] [Abstract][Full Text] [Related]
24. Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer.
Zsengellér ZK; Boivin GP; Sawchuk SS; Trapnell BC; Whitsett JA; Hirsch R
Hum Gene Ther; 1997 May; 8(8):935-41. PubMed ID: 9195216
[TBL] [Abstract][Full Text] [Related]
25. "Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung.
Croyle MA; Chirmule N; Zhang Y; Wilson JM
J Virol; 2001 May; 75(10):4792-801. PubMed ID: 11312351
[TBL] [Abstract][Full Text] [Related]
26. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide.
Bouvet M; Fang B; Ekmekcioglu S; Ji L; Bucana CD; Hamada K; Grimm EA; Roth JA
Gene Ther; 1998 Feb; 5(2):189-95. PubMed ID: 9578838
[TBL] [Abstract][Full Text] [Related]
27. Transient cyclophosphamide treatment before intraportal readministration of an adenoviral vector can induce re-expression of the original gene construct in rat liver.
Kuriyama S; Tominaga K; Kikukawa M; Tsujimoto T; Nakatani T; Tsujinoue H; Okuda H; Nagao S; Mitoro A; Yoshiji H; Fukui H
Gene Ther; 1999 May; 6(5):749-57. PubMed ID: 10505097
[TBL] [Abstract][Full Text] [Related]
28. Second-generation adenoviral vectors do not prevent rapid loss of transgene expression and vector DNA from the arterial wall.
Wen S; Schneider DB; Driscoll RM; Vassalli G; Sassani AB; Dichek DA
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1452-8. PubMed ID: 10845857
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.
Chirmule N; Moffett J; Dhagat P; Tazelaar J; Wilson JM
Hum Gene Ther; 1999 Nov; 10(17):2839-46. PubMed ID: 10584929
[TBL] [Abstract][Full Text] [Related]
30. Neonatal cotton rats do not exhibit destructive immune responses to adenoviral vectors.
Zepeda M; Wilson JM
Gene Ther; 1996 Nov; 3(11):973-9. PubMed ID: 8940637
[TBL] [Abstract][Full Text] [Related]
31. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo.
Yang Y; Jooss KU; Su Q; Ertl HC; Wilson JM
Gene Ther; 1996 Feb; 3(2):137-44. PubMed ID: 8867861
[TBL] [Abstract][Full Text] [Related]
32. Liver toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors.
Everett RS; Hodges BL; Ding EY; Xu F; Serra D; Amalfitano A
Hum Gene Ther; 2003 Dec; 14(18):1715-26. PubMed ID: 14670123
[TBL] [Abstract][Full Text] [Related]
33. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody.
Chirmule N; Truneh A; Haecker SE; Tazelaar J; Gao Gp; Raper SE; Hughes JV; Wilson JM
J Immunol; 1999 Jul; 163(1):448-55. PubMed ID: 10384148
[TBL] [Abstract][Full Text] [Related]
34. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.
Yang Y; Su Q; Wilson JM
J Virol; 1996 Oct; 70(10):7209-12. PubMed ID: 8794368
[TBL] [Abstract][Full Text] [Related]
35. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion.
DeMatteo RP; Markmann JF; Kozarsky KF; Barker CF; Raper SE
Gene Ther; 1996 Jan; 3(1):4-12. PubMed ID: 8929906
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
37. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
Ilan Y; Prakash R; Davidson A; Jona ; Droguett G; Horwitz MS; Chowdhury NR; Chowdhury JR
J Clin Invest; 1997 Mar; 99(5):1098-106. PubMed ID: 9062369
[TBL] [Abstract][Full Text] [Related]
38. Immunologic barriers to hepatic adenoviral gene therapy for transplantation.
DeMatteo RP; Chu G; Ahn M; Chang E; Burke C; Raper SE; Barker CF; Markmann JF
Transplantation; 1997 Jan; 63(2):315-9. PubMed ID: 9020337
[TBL] [Abstract][Full Text] [Related]
39. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.
Fields PA; Kowalczyk DW; Arruda VR; Armstrong E; McCleland ML; Hagstrom JN; Pasi KJ; Ertl HC; Herzog RW; High KA
Mol Ther; 2000 Mar; 1(3):225-35. PubMed ID: 10933938
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver.
Zhang HG; Zhou T; Yang P; Edwards CK; Curiel DT; Mountz JD
Hum Gene Ther; 1998 Sep; 9(13):1875-84. PubMed ID: 9741426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
